Abstract
C38H34N2O4, triclinic,
The molecular structure is shown in Figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Data collection and handling.
Crystal: | Colourless block |
Size: | 0.18 × 0.16 × 0.15 mm |
Wavelength: | Mo Kα radiation (0.71073 Å) |
μ: | 0.09 mm−1 |
Diffractometer, scan mode: | Bruker APEX-II, φ and ω |
θmax, completeness: | 27.5°, 99% |
N(hkl)measured, N(hkl)unique, Rint: | 9220, 6596, 0.016 |
Criterion for Iobs, N(hkl)gt: | Iobs > 2σ(Iobs), 5121 |
N(param)refined: | 399 |
Programs: | Bruker [1], SHELX [2, 3] |
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).
Atom | x | y | z | Uiso*/Ueq |
---|---|---|---|---|
O1 | 0.43060 (10) | 0.33694 (12) | 0.25888 (11) | 0.0486 (3) |
O2 | 0.41268 (10) | 0.44641 (12) | 0.38234 (10) | 0.0492 (3) |
O3 | 1.07900 (12) | 0.56210 (16) | 0.16452 (12) | 0.0692 (5) |
O4 | 0.98680 (11) | 0.54287 (13) | 0.34253 (10) | 0.0536 (4) |
N1 | 0.71403 (11) | 0.63020 (11) | 0.21005 (10) | 0.0307 (3) |
N2 | 0.74671 (10) | 0.30828 (11) | 0.35398 (10) | 0.0302 (3) |
C1 | 1.04233 (16) | 0.17146 (17) | 0.15810 (18) | 0.0514 (5) |
H1 | 1.030837 | 0.194130 | 0.083546 | 0.062* |
C2 | 1.11000 (19) | 0.06188 (19) | 0.1988 (2) | 0.0656 (6) |
H2 | 1.142688 | 0.011300 | 0.152270 | 0.079* |
C3 | 1.12887 (18) | 0.0278 (2) | 0.3081 (2) | 0.0717 (7) |
H3 | 1.174450 | −0.045941 | 0.336023 | 0.086* |
C4 | 1.07979 (17) | 0.1037 (2) | 0.3770 (2) | 0.0623 (6) |
H4 | 1.092537 | 0.080719 | 0.451179 | 0.075* |
C5 | 1.01157 (15) | 0.21393 (18) | 0.33553 (16) | 0.0491 (4) |
H5 | 0.979509 | 0.264685 | 0.382042 | 0.059* |
C6 | 0.99089 (13) | 0.24892 (15) | 0.22523 (14) | 0.0396 (4) |
C7 | 0.92002 (13) | 0.36777 (14) | 0.17107 (12) | 0.0348 (3) |
H7 | 0.972447 | 0.405381 | 0.097995 | 0.042* |
C8 | 0.88342 (12) | 0.47221 (14) | 0.22896 (12) | 0.0319 (3) |
C9 | 0.81264 (13) | 0.57168 (14) | 0.14110 (11) | 0.0324 (3) |
H9 | 0.867530 | 0.632637 | 0.085875 | 0.039* |
C10 | 0.75604 (13) | 0.49305 (15) | 0.08349 (12) | 0.0345 (3) |
H10 | 0.785948 | 0.514756 | 0.001409 | 0.041* |
C11 | 0.79379 (13) | 0.35783 (14) | 0.14407 (12) | 0.0337 (3) |
H11 | 0.798609 | 0.302025 | 0.097085 | 0.040* |
C12 | 0.69248 (12) | 0.32287 (13) | 0.25424 (11) | 0.0306 (3) |
H12 | 0.650261 | 0.249372 | 0.260418 | 0.037* |
C13 | 0.60202 (12) | 0.44331 (13) | 0.24500 (11) | 0.0299 (3) |
C14 | 0.66390 (12) | 0.52218 (13) | 0.29893 (11) | 0.0284 (3) |
H14 | 0.607939 | 0.544653 | 0.362330 | 0.034* |
C15 | 0.77867 (12) | 0.43449 (13) | 0.33603 (11) | 0.0289 (3) |
H15 | 0.800076 | 0.445776 | 0.403415 | 0.035* |
C16 | 0.74712 (13) | 0.73169 (13) | 0.23860 (12) | 0.0322 (3) |
C17 | 0.73080 (15) | 0.73823 (16) | 0.34895 (14) | 0.0416 (4) |
H17 | 0.696713 | 0.673274 | 0.409280 | 0.050* |
C18 | 0.76563 (18) | 0.84230 (18) | 0.36893 (16) | 0.0548 (5) |
H18 | 0.753605 | 0.846053 | 0.443050 | 0.066* |
C19 | 0.81710 (17) | 0.93929 (18) | 0.28242 (17) | 0.0558 (5) |
H19 | 0.841967 | 1.007025 | 0.297458 | 0.067* |
C20 | 0.83132 (18) | 0.93455 (17) | 0.17267 (17) | 0.0546 (5) |
H20 | 0.865425 | 1.000005 | 0.112908 | 0.065* |
C21 | 0.79526 (16) | 0.83324 (16) | 0.15077 (14) | 0.0454 (4) |
H21 | 0.803199 | 0.832644 | 0.076115 | 0.054* |
C22 | 0.61473 (13) | 0.50144 (14) | 0.11513 (12) | 0.0337 (3) |
H22 | 0.585652 | 0.441173 | 0.086356 | 0.040* |
C23 | 0.54602 (15) | 0.62529 (15) | 0.07012 (13) | 0.0390 (4) |
C24 | 0.60661 (18) | 0.72672 (19) | −0.00652 (17) | 0.0575 (5) |
H24 | 0.691986 | 0.719685 | −0.029116 | 0.069* |
C25 | 0.5418 (2) | 0.8377 (2) | −0.0495 (2) | 0.0786 (7) |
H25 | 0.584379 | 0.904547 | −0.099898 | 0.094* |
C26 | 0.4155 (2) | 0.8509 (2) | −0.0191 (2) | 0.0747 (7) |
H26 | 0.372717 | 0.926176 | −0.047961 | 0.090* |
C27 | 0.3534 (2) | 0.7514 (2) | 0.05451 (18) | 0.0615 (5) |
H27 | 0.267785 | 0.758896 | 0.075170 | 0.074* |
C28 | 0.41778 (16) | 0.63963 (18) | 0.09822 (14) | 0.0470 (4) |
H28 | 0.374321 | 0.572757 | 0.147426 | 0.056* |
C29 | 0.68045 (12) | 0.24302 (13) | 0.46162 (12) | 0.0292 (3) |
C30 | 0.65222 (14) | 0.29058 (15) | 0.55398 (13) | 0.0376 (3) |
H30 | 0.675482 | 0.369469 | 0.546073 | 0.045* |
C31 | 0.58983 (16) | 0.22175 (18) | 0.65769 (14) | 0.0476 (4) |
H31 | 0.572065 | 0.254901 | 0.718665 | 0.057* |
C32 | 0.55378 (16) | 0.10502 (18) | 0.67175 (15) | 0.0500 (4) |
H32 | 0.510939 | 0.059688 | 0.741309 | 0.060* |
C33 | 0.58199 (16) | 0.05666 (16) | 0.58164 (16) | 0.0488 (4) |
H33 | 0.558509 | −0.022423 | 0.590529 | 0.059* |
C34 | 0.64494 (15) | 0.12373 (15) | 0.47752 (14) | 0.0406 (4) |
H34 | 0.663776 | 0.088962 | 0.417553 | 0.049* |
C35 | 0.30507 (16) | 0.3035 (2) | 0.30004 (18) | 0.0573 (5) |
H35A | 0.250371 | 0.373478 | 0.271723 | 0.086* |
H35B | 0.288198 | 0.279568 | 0.381335 | 0.086* |
H35C | 0.292657 | 0.234958 | 0.274590 | 0.086* |
C36 | 0.47204 (13) | 0.41176 (14) | 0.30550 (12) | 0.0328 (3) |
C37 | 1.0814 (2) | 0.6115 (3) | 0.3553 (2) | 0.0775 (7) |
H37A | 1.160365 | 0.566957 | 0.343338 | 0.116* |
H37B | 1.063779 | 0.620733 | 0.430278 | 0.116* |
H37C | 1.082978 | 0.692274 | 0.300708 | 0.116* |
C38 | 0.99411 (14) | 0.52876 (15) | 0.24132 (13) | 0.0377 (3) |
Source of material
Preparation of the 1,4-diaryl-1,4-dihydropyridine-3-carboxylic acid photoreactive raw materials was performed by a literature method [4]: aniline (0.5 mmol), ethyl propiolate (0.5 mmol) and 4-methylcinnamaldehyde (0.5 mmol); piperazine (0.25 mmol) and p-toluenesulfonic acid (0.02 mmol) used as catalysts, and 20 mL of 1,2-dichloroethane (20 mL) were mixed. The mixture was heated to reflux for 12 h to obtain 1-phenyl-4-(4-methyl-phenyl)-1,4-dihydroethylpyridine-3-carboxylate. The 1-phenyl-4-(4-methyl-phenyl)-1,4-dihydroethylpyridine-3-carboxylate (0.5 mmol) obtained in the first step was placed near a blue LED (365 nm) for a photoreaction for 3 h [5]. The product was obtained by column chromatography eluting with petroleum ether and ethyl acetate 10:1. The resulting solution was evaporated to get some colorless crystals.
Experimental details
All hydrogen atoms were placed in the calculated positions.
Comment
Cage dimer 4-aryl-1,4-dihydropyridines have a wide range of biological activities, such as anti-HIV and as an antimultidrug resistance modulator [6], [7], [8]. The caged dimeric compound similar to the title compound has also been reported, which is obtained by a dimerization by photoreaction. However, the two pyridine rings in the title compound present a special angle, which may be of interest for the study of new functional caged compounds.
In the molecules forming the title crystal structure, the tricyclic structure formed by oxazinoquinoline structure is not in one plane. The dihedral angle of the phenyl ring formed by C23–28 and the phenyl ring formed by C6–C1 is 57°. The dihedral angle between the phenyl ring formed by C16–18 and the phenyl ring formed by C29–34 is 33.322 Å, close to a right angle. Several important bond angle data are involved as follows C2–C1–C6 = 121.9(2) Å, C36–O1–C35 = 117.56(13) Å, C16–N1–C14 = 120.10(11) Å. The bond lengths and angles are in the expected ranges [9, 10].
Funding source: Hebei Provincial Natural Science Foundation of China
Award Identifier / Grant number: C2020209081
-
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
-
Research funding: This work is supported by The Project Supported by Hebei Provincial Natural Science Foundation of China (C2020209081).
-
Conflict of interest statement: The authors declare no conflicts of interest regarding this article.
References
1. BRUKER. SAINT. Version 8.23B; Bruker AXS Inc.: Madison, Wisconsin, USA, 2013.Search in Google Scholar
2. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Search in Google Scholar
3. Sheldrick, G. M. A short history of SHELX. Acta Crystallogr. 2008, A64, 112–122; https://doi.org/10.1107/s0108767307043930.Search in Google Scholar
4. Wan, J. P., Lin, Y. F., Jing, Y. F. Selectivity tunable divergent synthesisof 1,4-and 1,2-dihydropyridines via three-component reactions. Tetrahedron 2014, 70, 7874–7880; https://doi.org/10.1016/j.tet.2014.09.002.Search in Google Scholar
5. Hilgeroth, A., Baumeister, U., Heinemann, F. W. Solution dimerization of 4-ary-1,4-dihydropyridines. Eur. J. Org Chem. 2000, 2000, 245–249; https://doi.org/10.1002/(sici)1099-0690(200001)2000:2<245::aid-ejoc245>3.0.co;2-2.10.1002/(SICI)1099-0690(200001)2000:2<245::AID-EJOC245>3.0.CO;2-2Search in Google Scholar
6. Hilgeroth, A., Langner, A. First bioanalytical evaluation of nonpeptidic cage dimeric HIV-1 protease inhibitor N-benzyl 4-aryl-1,4-dihydropyridine H17: biotransformation and toxicity on Hep G2 cells. Arch. Pharm. 2000, 333, 32–34; https://doi.org/10.1002/(sici)1521-4184(200001)333:1<32::aid-ardp32>3.0.co;2-q.10.1002/(SICI)1521-4184(200001)333:1<32::AID-ARDP32>3.0.CO;2-QSearch in Google Scholar
7. Hilgeroth, A., Billich, A. Cage dimeric 4-aryl-1,4-dihydropyridines as promising lead structures for the development of a novel class of HIV-1 protease inhibitors. Arch. Pharm. 1999, 332, 3–5; https://doi.org/10.1002/(sici)1521-4184(19991)332:1<3::aid-ardp3>3.0.co;2-1.10.1002/(SICI)1521-4184(19991)332:1<3::AID-ARDP3>3.0.CO;2-1Search in Google Scholar
8. Coburger, C., Wollmann, J., Krug, M., Baumert, C., Seifert, M., Molnar, J., Lage, H., Hilgeroth, A. Novel structure-activity relationships and selectivity profiling of cage dimeric 1,4-dihydropyridines as multidrug resistance (MDR) modulators. Bioorg. Med. Chem. 2010, 18, 4983–4990; https://doi.org/10.1016/j.bmc.2010.06.004.Search in Google Scholar
9. Hilgeroth, A., Baumeister, U. The first functionalized 6,12-diazatetrakishomocubanes. Angew. Chem. Int. Ed. 2000, 39, 576–578; https://doi.org/10.1002/(sici)1521-3773(20000204)39:3<576::aid-anie576>3.0.co;2-g.10.1002/(SICI)1521-3773(20000204)39:3<576::AID-ANIE576>3.0.CO;2-GSearch in Google Scholar
10. Wang, X., Zhang, D., Zhuang, P., Zhang, Y., Xu, J. Crystal structure of 3,10-bis(4-chlorophenyl)-6,12-dibenzyl-2,9-acetyl-6,12-diazapentacyclo [6.3.1.02,7.04,11.05,9]-dodecane, C40H36Cl2N2O2. Z. Kristallogr. N. Cryst. Struct. 2020, 235, 587–588; https://doi.org/10.1515/ncrs-2019-0834.Search in Google Scholar
© 2022 Yin-Xin Wang et al., published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution 4.0 International License.
Articles in the same Issue
- Frontmatter
- New Crystal Structures
- Crystal structure of (E)-(4-imidazol-1-yl-phenyl)-(2-methoxy-benzylidene)-amine monohydrate, C17H17N3O2
- Crystal structure of 6-methyl-3-(pyrrolidine-1-carbonyl)-2H-chromen-2-one, C15H15N1O3
- Crystal structure of 4-methyl-4-nitropentanoic acid, C6H11NO4
- The crystal structure of (E)-3-(furan-2-yl)acrylonitrile, C7H5NO
- Crystal structure of 3-(difluoromethyl)-1-methyl-N-(4,11,11-trimethyl-1,2,3,4-tetrahydro-1,4-methanoacridin-9-yl)-1H-pyrazole-4-carboxamide monohydrate, C23H26F2N4O3
- Crystal structure of 2-(4-bromobenzyloxy)-6-chloropyridine, C12H9BrClNO
- Crystal structure of N-(4-bromo-2,6-dichloro-phenyl)pyrazin-2-amine, C10H6BrCl2N3
- Crystal structure of (E)-1-(2–nitrophenyl)-3-phenylprop-2-en-1-one, C15H11NO3
- The crystal structure of (E)-3-chloro-2-(2-(4-fluorobenzylidene)hydrazinyl)pyridine, C12H9ClFN3
- Crystal structure of (E)-amino(2-(thiazol-2-ylmethylene)hydrazineyl)methaniminium nitrate, C10H16N12O6S2
- Crystal structure of 9-methoxy-2,3,4,4a,5,6-hexahydro-1H-pyrido [1′,2′:1,6]pyrazino[2,3-b]quinoxaline, C15H18N4O
- The crystal structure bis(dimethylsulfoxide-κ1O)-dipyridine-κ1 N-bis(m2-(Z)-3-methyl-2-oxido-N-((Z)-oxido(phenyl)methylene)benzohydrazonato-κ5)trinickel(II) - dimethylsulfoxide (1/2), C48H56N6Ni3O10S4
- Crystal structure of bis(bis(triphenylphosphine)iminium) tetradecacarbonyltetratelluridopentaferrate(2-), (PPN)2[Fe5Te4(CO)14]
- Crystal structure of 4-Hydroxy-3-(naphthalen-2-ylthio)pent-3-en-2-one, C15H14O2S
- The crystal structure of [(1,10-phenanthroline-κ2 N,N)-bis(6-phenylpyridine-2-carboxylate-κ2 N,O)nickel(II)] monohydrate, C36H26N4O5Ni
- Crystal structure of 3,3′-(pyridine-2,6-diylbis(methylene))bis(1-propyl-1H-imidazol-3-ium) ditetrafluoroborate, C19H27B2F8N5
- The crystal structure of (E)-1-(4-aminophenyl)-3-(p-tolyl)prop-2-en-1-one, C16H15NO
- The crystal structure of poly[(μ2-terephthalato-κ4O,O′: O″,O‴)-(μ4-terephthalato-κ4O:O′:O″:O‴)-{μ4-(1,2,4,5-tetrakis(1,2,4-triazol-1-ylmethyl)-benzene-κ4O:O′:O″,O‴)}dicadmium(II)] – water – acetronitrile (1/2/2), C38H36N14O10Cd2
- The crystal structure of diaqua-bis(6-phenylpyridine-2-carboxylato-κ2 N,O)cobalt(II)–water–N,N-dimethylformamide(1/2/1), C27H31N3O9Co
- The co-crystal structure of 4-hydroxy-3-methoxybenzoic acid – 4,4′-bipyridine, C8H8O4·C10H8N2
- Crystal structure of catena-poly[(μ2-1,1′-(biphenyl-4,4′-diyl)bis(1H-imidazol)-κ2N:N′)-bis(4-bromobenzoate-κ1O)cobalt(II)], C32H22Br2CoN4O4
- Crystal structure of (E)-5-propyl-4-((pyridin-2-ylmethylene)amino)-2,4-dihydro-3H-1,2,4-triazole-3-thione – methanol (1/1), C11H13N5S
- The crystal structure of (Z)-4-bromo-6-(((1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)amino)methylene)cyclohexa-2,4-dien-1-one monohydrate, C11H16BrNO5
- Crystal structure of bis(tetrapropylammonium) nonaselenidotetrastannate(IV), (Pr4N)2[Sn4Se9]
- Crystal structure of 2,6-di-tert-butyl-4-(4-chlorobenzylidene)cyclohexa-2,5-dien-1-one, C21H25ClO
- Crystal structure of (2,2′-((naphthalen-1-ylmethyl)azanediyl)diacetato-κ3 N,O,O′)-(1,10-phenanthroline-κ2 N,N′)-copper(II) trihydrate, CuC27H27N3O7
- The crystal structure of tetrakis(6-phenylpyridine-2-carboxylato-κ2N,O)-bis(1H-pyrazol-3-ylamine-κ2 N:N)dicobalt(II) dihydrate, C27H23N5O5Co
- The crystal structure of bis((E)-2-((tert-butylimino)methyl)-4-chlorophenolato-κ2N,O)zinc(II), C22H26Cl2N2O2Zn
- The crystal structure of poly[diaqua-(μ3-5-nitrobenzene-1,2,3-tricarboxylato-κ3O:O′:O′)-(μ2-4,4′-dipyridylamine-κ2N:N′)copper(II)], C38H30Cu3N8O20
- The crystal structure of (E)-1-ferrocenyl-3-(naphthalen-1-yl)prop-2-en-1-one, C23H18FeO
- The crystal structure of (E)-1-ferrocenyl-3-(4-isopropylphenyl)prop-2-en-1-one, C22H22FeO
- Crystal structure of 6-hydroxy-2,2-dimethyl-4Hbenzo[d][1,3]dioxin-4-one, C10H10O4
- The crystal structure of (2E,4E)-1-ferrocenyl-5-phenylpenta-2,4-dien-1-one, C21H18FeO
- Crystal structure of alaninato-κ2N,O-bis(hydroxylamido-κ2N,O)-oxido-vanadium(V), C3H10N3O5V
- Crystal structure of catena-poly[aqua-bis[μ2-6-(1H-imidazol-1-yl)nicotinato-κ2 N,O]copper(II)], C18H14N6O5Cu
- Crystal structure of diethyl 4,6-diphenyl-1,9-di-p-tolylhexahydro-3H-2,7,3,5-(epimethanetriyliminomethanetriyl)cyclopenta[b]pyridine-3,5(2H)-dicarboxylate, C42H42N2O4
- The crystal structure of cobalt cadmium bis(hydrogenphosphate) bis(phosphate(V)) tetrahydrate, H10O20P4Co3.14Cd1.86
- Crystal structure of dimethyl 1,4,6,9-tetraphenylhexahydro-3H-2,7,3,5-(epimethanetriyliminomethanetriyl)cyclopenta[b]pyridine-3,7(2H)-dicarboxylate, C38H34N2O4
- Crystal structure of (Z)-4-(furan-2-yl((4-iodophenyl)amino)methylene)-5-methyl-2(p-tolyl)-2,4-dihydro-3H-pyrazol-3-one, C21H16I N3O2
- Crystal structure of (E)-1-(4-(3,5-dimethoxystyryl)phenyl)-7-ethylheptanedioate, C25H30O6
- Crystal structure of 6-bromo-2-(4-chlorophenyl)chroman-4-one (6-bromo-4′-chloroflavanone), C15H10BrClO2
- The crystal structure of 2-(benzhydryloxy)-3-nitropyridine, C18H14N2O3
- The crystal structure of 1,3(4,1)-dipyridin-1-iuma-2(1,8)-diethynylanthracena-5(1,3)-benzenacyclohexaphane-11,31-diium bis(hexafluoridophosphate), C36H24F12N2P2
- Crystal structure of 3,6-di-tert-butyl-1-iodo-9-methyl-8-(pyren-1-ylethynyl)-9H-carbazole, C39H34IN
- The cocrystal 2-(dimethylammonio)-5-nitrobenzoate – 2-(dimethylamino)-5-nitrobenzoic acid, C9H10N2O4
- Crystal structure of 5-nitroquinazolin-4(3H)-one, C8H5N3O3
Articles in the same Issue
- Frontmatter
- New Crystal Structures
- Crystal structure of (E)-(4-imidazol-1-yl-phenyl)-(2-methoxy-benzylidene)-amine monohydrate, C17H17N3O2
- Crystal structure of 6-methyl-3-(pyrrolidine-1-carbonyl)-2H-chromen-2-one, C15H15N1O3
- Crystal structure of 4-methyl-4-nitropentanoic acid, C6H11NO4
- The crystal structure of (E)-3-(furan-2-yl)acrylonitrile, C7H5NO
- Crystal structure of 3-(difluoromethyl)-1-methyl-N-(4,11,11-trimethyl-1,2,3,4-tetrahydro-1,4-methanoacridin-9-yl)-1H-pyrazole-4-carboxamide monohydrate, C23H26F2N4O3
- Crystal structure of 2-(4-bromobenzyloxy)-6-chloropyridine, C12H9BrClNO
- Crystal structure of N-(4-bromo-2,6-dichloro-phenyl)pyrazin-2-amine, C10H6BrCl2N3
- Crystal structure of (E)-1-(2–nitrophenyl)-3-phenylprop-2-en-1-one, C15H11NO3
- The crystal structure of (E)-3-chloro-2-(2-(4-fluorobenzylidene)hydrazinyl)pyridine, C12H9ClFN3
- Crystal structure of (E)-amino(2-(thiazol-2-ylmethylene)hydrazineyl)methaniminium nitrate, C10H16N12O6S2
- Crystal structure of 9-methoxy-2,3,4,4a,5,6-hexahydro-1H-pyrido [1′,2′:1,6]pyrazino[2,3-b]quinoxaline, C15H18N4O
- The crystal structure bis(dimethylsulfoxide-κ1O)-dipyridine-κ1 N-bis(m2-(Z)-3-methyl-2-oxido-N-((Z)-oxido(phenyl)methylene)benzohydrazonato-κ5)trinickel(II) - dimethylsulfoxide (1/2), C48H56N6Ni3O10S4
- Crystal structure of bis(bis(triphenylphosphine)iminium) tetradecacarbonyltetratelluridopentaferrate(2-), (PPN)2[Fe5Te4(CO)14]
- Crystal structure of 4-Hydroxy-3-(naphthalen-2-ylthio)pent-3-en-2-one, C15H14O2S
- The crystal structure of [(1,10-phenanthroline-κ2 N,N)-bis(6-phenylpyridine-2-carboxylate-κ2 N,O)nickel(II)] monohydrate, C36H26N4O5Ni
- Crystal structure of 3,3′-(pyridine-2,6-diylbis(methylene))bis(1-propyl-1H-imidazol-3-ium) ditetrafluoroborate, C19H27B2F8N5
- The crystal structure of (E)-1-(4-aminophenyl)-3-(p-tolyl)prop-2-en-1-one, C16H15NO
- The crystal structure of poly[(μ2-terephthalato-κ4O,O′: O″,O‴)-(μ4-terephthalato-κ4O:O′:O″:O‴)-{μ4-(1,2,4,5-tetrakis(1,2,4-triazol-1-ylmethyl)-benzene-κ4O:O′:O″,O‴)}dicadmium(II)] – water – acetronitrile (1/2/2), C38H36N14O10Cd2
- The crystal structure of diaqua-bis(6-phenylpyridine-2-carboxylato-κ2 N,O)cobalt(II)–water–N,N-dimethylformamide(1/2/1), C27H31N3O9Co
- The co-crystal structure of 4-hydroxy-3-methoxybenzoic acid – 4,4′-bipyridine, C8H8O4·C10H8N2
- Crystal structure of catena-poly[(μ2-1,1′-(biphenyl-4,4′-diyl)bis(1H-imidazol)-κ2N:N′)-bis(4-bromobenzoate-κ1O)cobalt(II)], C32H22Br2CoN4O4
- Crystal structure of (E)-5-propyl-4-((pyridin-2-ylmethylene)amino)-2,4-dihydro-3H-1,2,4-triazole-3-thione – methanol (1/1), C11H13N5S
- The crystal structure of (Z)-4-bromo-6-(((1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)amino)methylene)cyclohexa-2,4-dien-1-one monohydrate, C11H16BrNO5
- Crystal structure of bis(tetrapropylammonium) nonaselenidotetrastannate(IV), (Pr4N)2[Sn4Se9]
- Crystal structure of 2,6-di-tert-butyl-4-(4-chlorobenzylidene)cyclohexa-2,5-dien-1-one, C21H25ClO
- Crystal structure of (2,2′-((naphthalen-1-ylmethyl)azanediyl)diacetato-κ3 N,O,O′)-(1,10-phenanthroline-κ2 N,N′)-copper(II) trihydrate, CuC27H27N3O7
- The crystal structure of tetrakis(6-phenylpyridine-2-carboxylato-κ2N,O)-bis(1H-pyrazol-3-ylamine-κ2 N:N)dicobalt(II) dihydrate, C27H23N5O5Co
- The crystal structure of bis((E)-2-((tert-butylimino)methyl)-4-chlorophenolato-κ2N,O)zinc(II), C22H26Cl2N2O2Zn
- The crystal structure of poly[diaqua-(μ3-5-nitrobenzene-1,2,3-tricarboxylato-κ3O:O′:O′)-(μ2-4,4′-dipyridylamine-κ2N:N′)copper(II)], C38H30Cu3N8O20
- The crystal structure of (E)-1-ferrocenyl-3-(naphthalen-1-yl)prop-2-en-1-one, C23H18FeO
- The crystal structure of (E)-1-ferrocenyl-3-(4-isopropylphenyl)prop-2-en-1-one, C22H22FeO
- Crystal structure of 6-hydroxy-2,2-dimethyl-4Hbenzo[d][1,3]dioxin-4-one, C10H10O4
- The crystal structure of (2E,4E)-1-ferrocenyl-5-phenylpenta-2,4-dien-1-one, C21H18FeO
- Crystal structure of alaninato-κ2N,O-bis(hydroxylamido-κ2N,O)-oxido-vanadium(V), C3H10N3O5V
- Crystal structure of catena-poly[aqua-bis[μ2-6-(1H-imidazol-1-yl)nicotinato-κ2 N,O]copper(II)], C18H14N6O5Cu
- Crystal structure of diethyl 4,6-diphenyl-1,9-di-p-tolylhexahydro-3H-2,7,3,5-(epimethanetriyliminomethanetriyl)cyclopenta[b]pyridine-3,5(2H)-dicarboxylate, C42H42N2O4
- The crystal structure of cobalt cadmium bis(hydrogenphosphate) bis(phosphate(V)) tetrahydrate, H10O20P4Co3.14Cd1.86
- Crystal structure of dimethyl 1,4,6,9-tetraphenylhexahydro-3H-2,7,3,5-(epimethanetriyliminomethanetriyl)cyclopenta[b]pyridine-3,7(2H)-dicarboxylate, C38H34N2O4
- Crystal structure of (Z)-4-(furan-2-yl((4-iodophenyl)amino)methylene)-5-methyl-2(p-tolyl)-2,4-dihydro-3H-pyrazol-3-one, C21H16I N3O2
- Crystal structure of (E)-1-(4-(3,5-dimethoxystyryl)phenyl)-7-ethylheptanedioate, C25H30O6
- Crystal structure of 6-bromo-2-(4-chlorophenyl)chroman-4-one (6-bromo-4′-chloroflavanone), C15H10BrClO2
- The crystal structure of 2-(benzhydryloxy)-3-nitropyridine, C18H14N2O3
- The crystal structure of 1,3(4,1)-dipyridin-1-iuma-2(1,8)-diethynylanthracena-5(1,3)-benzenacyclohexaphane-11,31-diium bis(hexafluoridophosphate), C36H24F12N2P2
- Crystal structure of 3,6-di-tert-butyl-1-iodo-9-methyl-8-(pyren-1-ylethynyl)-9H-carbazole, C39H34IN
- The cocrystal 2-(dimethylammonio)-5-nitrobenzoate – 2-(dimethylamino)-5-nitrobenzoic acid, C9H10N2O4
- Crystal structure of 5-nitroquinazolin-4(3H)-one, C8H5N3O3